Research and development of drug delivery technologies using extracellular vesicles and healthcare products utilizing Solid-in-Oil (S/O®) technology to enhance transdermal absorption efficiency
Company name
NOVIGO Pharma Inc.
Type of business
Medical(medical devices, drug discovery)
Representatives
Kohei Ishihama
Establishing a company
January 2021
Investment announcement date
May 2026
Capitalist
Yoshiharu Uruno
HP
https://www.novigopharma.co.jp/enPhasing
Early
